Intraputamenal cerebral dopamine neurotrophic factor in Parkinson's disease: A randomized, double‐blind, multicenter phase 1 trial
(2023)
Journal Article
Background: Cerebral dopamine neurotrophic factor (CDNF) is an unconventional neurotrophic factor that protects dopamine neurons and improves motor function in animal models of Parkinson's disease (PD). Objective: The primary objectives of this study... Read More about Intraputamenal cerebral dopamine neurotrophic factor in Parkinson's disease: A randomized, double‐blind, multicenter phase 1 trial.